版本:
中国

BRIEF-Amicus Therapeutics receives rare pediatric disease designation for SD-101 for patients with epidermolysis bullosa

May 31 Amicus Therapeutics Inc

* Amicus Therapeutics receives rare pediatric disease designation for SD-101 for patients with epidermolysis bullosa

* Amicus Therapeutics Inc - ‍top-line phase 3 data on track for 3Q17​ Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐